Description
Research Overview
Pinealon (EDR) is a synthetic tripeptide composed of glutamic acid, aspartic acid and arginine. It has been investigated in experimental research involving cellular stress responses, neuronal biology and mechanisms associated with cellular viability.
Research Focus
Experimental research has examined Pinealon in relation to oxidative stress, reactive oxygen species, cell viability, neuronal responses and signalling pathways involved in cellular regulation. Studies have included in-vitro and animal models.
Scientific Context
Research has also investigated the interaction of short regulatory peptides such as Pinealon with cellular and nuclear processes. Findings from these experimental models provide areas for further investigation but do not establish clinical efficacy or therapeutic application.
Important Research Note
Pinealon remains an investigational research compound. Available evidence is limited and includes predominantly experimental research, with some older human studies. Findings should not be interpreted as evidence that Pinealon is safe or effective for neurological conditions, ageing, cognitive function or any other human application.
For research purposes only. Not intended for human or veterinary use.
